Lectus Therapeutics' Seed VC Round

Lectus Therapeutics raised a round of funding on April 21, 2004. Investors include Takeda Ventures.

Lectus Therapeutics is a UK biopharmaceutical company with a proprietary functional proteomics screening platform (LEPTICS), enabling the discovery and development of novel, small molecule modulators …

Articles about Lectus Therapeutics' Seed VC Round: